Navigation Links
2008 Human Research Protection Award Recipients Announced
Date:12/29/2008

BETHESDA, Md., Dec. 29 /PRNewswire-USNewswire/ -- The winner of the 2008 Award for Excellence in Human Research Protection was announced today by Dr. Peter G. Goldschmidt, President and Founder of the Health Improvement Institute.

The winner of the annual award was the University of Texas M.D. Anderson Cancer Center -- for its best practice "IND Regulatory and Monitoring Program." This program provides for 1) enhanced human subjects protection, 2) improved data quality for clinical trials, 3) an active, vital relationship with federal agencies and 4) increased protection for institutions.

"The Award program offers a way to gain positive recognition for excellence in the field of human research protection," said Dr. Goldschmidt. "This year's winner continues the high standard in best practices that have been submitted for an Award since the program began."

Awards are given for demonstrated excellence in promoting the well being of people who participate in research. The Health Improvement Institute created this Award program. The Office of Human Research Protection was the founding sponsor of the Award program. Judges and Committee and Award Advisory Board members are volunteers. This year's judges were drawn from provider, research review, compliance, legal, and consulting organizations.

About Health Improvement Institute:

Health Improvement Institute is a non-profit, tax exempt, 501(c)3, charitable organization dedicated to improving the quality and productivity of America's health care. The Institute's principal program objective it to provide information to enable people to make informed health care choices. The Institute has established expertise in evaluating the quality of health information on the Internet, conducts forms and workshops, and sponsors national awards programs to recognize excellence, including the Award for Excellence in Human Research Protection. For more information, visit www.hii.org.

The Office for Human Research Protections (OHRP) -- together with the federal Food and Drug Administration -- oversees programs for the protections of human subjects at more than 4,000 HHS-funded universities, hospitals, and other medical and behavioral research institutions and private research sites in the United States and abroad.

For information about the 2009 Award for Excellence in Human Research Protection, please contact the Award Coordinator at 301-320-0965 or by email at hii@hii.org.


'/>"/>
SOURCE Health Improvement Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):